{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:13:39Z","timestamp":1790806419071,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,12,25]],"date-time":"2012-12-25T00:00:00Z","timestamp":1356393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00296-012-2628-5","type":"journal-article","created":{"date-parts":[[2012,12,24]],"date-time":"2012-12-24T04:03:23Z","timestamp":1356321803000},"page":"3105-3108","source":"Crossref","is-referenced-by-count":13,"title":["A young girl with refractory intestinal Beh\u00e7et\u2019s disease: a case report and review of literatures on pediatric cases who received an anti-tumor necrosis factor agent"],"prefix":"10.1007","volume":"33","author":[{"given":"Shojiro","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Aizawa-Yashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushi","family":"Tsuruga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Kinjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,25]]},"reference":[{"key":"2628_CR1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/rheumatology\/keq324","volume":"50","author":"I Kone-Paut","year":"2011","unstructured":"Kone-Paut I, Darce-Bello M, Shahram F et al (2011) Registries in rheumatological and musculoskeletal conditions. Paediatric Beh\u00e7et\u2019s disease: an international cohort study of 110 patients, On-year follow-up data. Rheumatology (Oxf) 50:184\u2013188","journal-title":"Rheumatology (Oxf)"},{"key":"2628_CR2","first-page":"71","volume":"4","author":"M Regina La","year":"2010","unstructured":"La Regina M, Gasparyan AY, Orlandini F, Prisco D (2010) Beh\u00e7et\u2019s disease as a model of venous thrombosis. Open Cardiovasc Med J 4:71\u201377","journal-title":"Open Cardiovasc Med J"},{"key":"2628_CR3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/art.11204","volume":"49","author":"FT Saulsbury","year":"2003","unstructured":"Saulsbury FT, Mann JA (2003) Treatment with infliximab for a child with Beh\u00e7et\u2019s disease. Arthritis Rheum 49:599\u2013600","journal-title":"Arthritis Rheum"},{"key":"2628_CR4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2177\/jsci.33.157","volume":"33","author":"U Kaneko","year":"2010","unstructured":"Kaneko U, Kishi T, Kikuchi M et al (2010) Two patients with childhood-onset Beh\u00e7et\u2019s disease successfully treated by anti-tumor necrosis factor therapy. Jpn J Clin Immunol 33:157\u2013161","journal-title":"Jpn J Clin Immunol"},{"key":"2628_CR5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ibd.20970","volume":"16","author":"K Matsumura","year":"2010","unstructured":"Matsumura K, Nakase H, Chiba T (2010) Efficacy of oral tacrolimus on intestinal Beh\u00e7et\u2019s disease. Inflamm Bowel Dis 16:188\u2013189","journal-title":"Inflamm Bowel Dis"},{"key":"2628_CR6","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/rheumatology\/kem034","volume":"46","author":"PP Sfikakis","year":"2007","unstructured":"Sfikakis PP, Markomichelakis N, Alpsoy E et al (2007) Anti-TNF therapy in the management of Beh\u00e7et\u2019s disease\u2014review and basis for recommendations. Rheumatology (Oxf) 46:736\u2013741","journal-title":"Rheumatology (Oxf)"},{"key":"2628_CR7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00296-009-1213-z","volume":"31","author":"AR Giardina","year":"2011","unstructured":"Giardina AR, Ferrante A, Ciccia F, Vadala M, Giardina E, Triolo G (2011) One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Beh\u00e7et\u2019s disease refractory to standard immunosuppressive drugs. Rheumatol Int 31:33\u201337","journal-title":"Rheumatol Int"},{"key":"2628_CR8","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00296-009-1276-x","volume":"31","author":"NE Aikawa","year":"2011","unstructured":"Aikawa NE, Gon\u00e7alves C, Silva CAA, Gon\u00e7alves C, Bonfa E, de Carvalho JF (2011) Late response to anti-TNF-\u03b1 therapy in refractory mucocutaneous lesions of Beh\u00e7et\u2019s disease. Rheumatol Int 31:1097\u20131099","journal-title":"Rheumatol Int"},{"key":"2628_CR9","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00296-011-1915-x","volume":"32","author":"U Studer","year":"2012","unstructured":"Studer U, Ruehe B, Waldegg G, Vajtai I, Escher R, Aeberli D (2012) Atypical presentation of Beh\u00e7et\u2019s disease with central nervous system involvement successfully treated with infliximab. Rheumatol Int 32:1431\u20131435","journal-title":"Rheumatol Int"},{"key":"2628_CR10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/rheumatology\/kem103","volume":"46","author":"E Seyahi","year":"2007","unstructured":"Seyahi E, Hamurydan V, Hatemi G et al (2007) Infliximab in the treatment of hepatic vein thrombosis (Budd\u2013Chiari syndrome) in three patients with Beh\u00e7et\u2019s disease. Rheumatology (Oxf) 46:1213\u20131214","journal-title":"Rheumatology (Oxf)"},{"key":"2628_CR11","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1136\/bjo.2007.127522","volume":"92","author":"C Evereklioglu","year":"2008","unstructured":"Evereklioglu C, Borlu M (2008) Sustained remission after infliximab in a child with vasculitis refractory to conventional immunosuppressives including interferon-\u03b1. Br J Ophthalmol 92:1148\u20131149","journal-title":"Br J Ophthalmol"},{"key":"2628_CR12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/039463200902200235","volume":"22","author":"L Cantarini","year":"2009","unstructured":"Cantarini L, Tinazzi I, Caramaschi P, Bellisai F, Brogna A, Galeazzi M (2009) Safety and efficacy of etanercept in children with juvenile-onset Beh\u00e7et\u2019s disease. Int J Immunopathol Phamacol 22:551\u2013555","journal-title":"Int J Immunopathol Phamacol"},{"key":"2628_CR13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.pediatrneurol.2010.04.021","volume":"43","author":"AB Robinson","year":"2010","unstructured":"Robinson AB, Gallentine WB, Rabinovich CE (2010) Pediatric neuro-Beh\u00e7et\u2019s disease responsive to adalimumab. Pediatr Neurol 43:291\u2013293","journal-title":"Pediatr Neurol"},{"key":"2628_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03857.x","volume":"156","author":"MT Keogan","year":"2009","unstructured":"Keogan MT (2009) Clinical immunology review series: an approach to the patient with recurrent orogenital ulceration, including Beh\u00e7et\u2019s syndrome. Clin Exp Immunol 156:1\u201311","journal-title":"Clin Exp Immunol"},{"key":"2628_CR15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1620\/tjem.225.117","volume":"225","author":"S Watanabe","year":"2011","unstructured":"Watanabe S, Tsuruga K, Aizawa-Yashiro T, Takahashi T, Ito E, Tanaka H (2011) Successful multidrug treatment of a pediatric case of severe Churg\u2013Strauss syndrome refractory to prednisolone. Tohoku J Exp Med 225:117\u2013121","journal-title":"Tohoku J Exp Med"},{"key":"2628_CR16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00296-009-1178-y","volume":"31","author":"K Takase","year":"2011","unstructured":"Takase K, Ohno S, Ideguchi H, Uchio E, Takeno M, Ishigatsubo Y (2011) Successful switching to adalimumab in an infliximab-allergic patient with severe Beh\u00e7et\u2019s disease-related uveitis. Rheumatol Int 31:243\u2013245","journal-title":"Rheumatol Int"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2628-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-012-2628-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-012-2628-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,7]],"date-time":"2019-07-07T15:10:22Z","timestamp":1562512222000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-012-2628-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,25]]},"references-count":16,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2628"],"URL":"https:\/\/doi.org\/10.1007\/s00296-012-2628-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,25]]}}}